The use of conventional risk factors, such as serum cholesterol, blood pressure, obesity, and smoking, fails to identify a considerable proportion (30 %) of individuals at risk of CVD.7 The combination of traditional risk factors and emerging risk factors is expected to facilitate the assessment of patients’ global risk, thereby allowing optimal use of diagnostic and therapeutic efforts in high-risk subjects.8